Pfizer Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Pfizer de 14.5% y 8.1% por año respectivamente. Se prevé que el BPA crezca en un 14.5% al año. Se espera que la rentabilidad financiera sea de 16.4% en 3 años.
Información clave
14.5%
Tasa de crecimiento de los beneficios
14.5%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Pharmaceuticals | 18.0% |
Tasa de crecimiento de los ingresos | 8.1% |
Rentabilidad financiera futura | 16.4% |
Cobertura de analistas | Low |
Última actualización | 19 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Pfizer (NSE:PFIZER) Has A Pretty Healthy Balance Sheet
Feb 13Pfizer Limited's (NSE:PFIZER) Business Is Yet to Catch Up With Its Share Price
Jan 17Here's Why Pfizer (NSE:PFIZER) Can Manage Its Debt Responsibly
Mar 15A Look At The Intrinsic Value Of Pfizer Limited (NSE:PFIZER)
Jul 20Pfizer (NSE:PFIZER) Could Easily Take On More Debt
Mar 29Calculating The Fair Value Of Pfizer Limited (NSE:PFIZER)
Feb 07These 4 Measures Indicate That Pfizer (NSE:PFIZER) Is Using Debt Safely
Sep 23This Is The Reason Why We Think Pfizer Limited's (NSE:PFIZER) CEO Deserves A Bump Up To Their Compensation
Aug 12Are Institutions Heavily Invested In Pfizer Limited's (NSE:PFIZER) Shares?
Mar 10Why Dividend Hunters Love Pfizer Limited (NSE:PFIZER)
Feb 17Are Pfizer's (NSE:PFIZER) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 02Need To Know: Pfizer Limited (NSE:PFIZER) Insiders Have Been Buying Shares
Jan 18Is Pfizer Limited's (NSE:PFIZER) Stock's Recent Performance A Reflection Of Its Financial Health?
Jan 03What Can We Learn About Pfizer's (NSE:PFIZER) CEO Compensation?
Dec 18Here's What Pfizer Limited's (NSE:PFIZER) Shareholder Ownership Structure Looks Like
Dec 03Did You Participate In Any Of Pfizer's (NSE:PFIZER) Fantastic 174% Return ?
Nov 18Are Pfizer's (NSE:PFIZER) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 03Need To Know: Pfizer Limited (NSE:PFIZER) Insiders Have Been Buying Shares
Oct 20Pfizer Limited's (NSE:PFIZER) Stock Is Going Strong: Is the Market Following Fundamentals?
Oct 02Why Pfizer's (NSE:PFIZER) CEO Pay Matters
Sep 17Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
3/31/2026 | 26,332 | 6,803 | 4,901 | N/A | 3 |
3/31/2025 | 23,806 | 5,878 | 4,631 | N/A | 3 |
3/31/2024 | 22,007 | 5,015 | 5,028 | N/A | 3 |
12/31/2023 | 22,192 | 5,021 | N/A | N/A | N/A |
9/30/2023 | 23,010 | 5,228 | 4,322 | 5,040 | N/A |
6/30/2023 | 23,632 | 6,849 | N/A | N/A | N/A |
3/31/2023 | 24,248 | 6,239 | 2,907 | 3,557 | N/A |
12/31/2022 | 24,041 | 6,201 | N/A | N/A | N/A |
9/30/2022 | 24,583 | 6,133 | 1,341 | 1,493 | N/A |
6/30/2022 | 24,571 | 4,452 | N/A | N/A | N/A |
3/31/2022 | 26,110 | 6,126 | 6,518 | 6,671 | N/A |
12/31/2021 | 25,961 | 5,873 | N/A | N/A | N/A |
9/30/2021 | 25,137 | 5,847 | 7,018 | 7,147 | N/A |
6/30/2021 | 24,728 | 5,731 | N/A | N/A | N/A |
3/31/2021 | 22,404 | 4,976 | 4,096 | 4,273 | N/A |
12/31/2020 | 22,058 | 5,001 | N/A | N/A | N/A |
9/30/2020 | 21,505 | 4,979 | 4,129 | 4,004 | N/A |
6/30/2020 | 21,221 | 5,208 | N/A | N/A | N/A |
3/31/2020 | 21,517 | 5,091 | 3,211 | 3,232 | N/A |
12/31/2019 | 21,853 | 5,156 | N/A | N/A | N/A |
9/30/2019 | 21,609 | 5,085 | 1,760 | 1,716 | N/A |
6/30/2019 | 21,136 | 4,500 | N/A | N/A | N/A |
3/31/2019 | 20,815 | 4,291 | 1,245 | 978 | N/A |
12/31/2018 | 20,658 | 4,241 | N/A | N/A | N/A |
9/30/2018 | 20,085 | 3,794 | N/A | N/A | N/A |
6/30/2018 | 20,599 | 3,947 | N/A | N/A | N/A |
3/31/2018 | 19,685 | 3,601 | 2,291 | 3,318 | N/A |
12/31/2017 | 18,866 | 3,236 | N/A | N/A | N/A |
9/30/2017 | 19,215 | 2,987 | N/A | N/A | N/A |
6/30/2017 | 18,860 | 3,139 | N/A | N/A | N/A |
3/31/2017 | 19,663 | 3,368 | N/A | 3,288 | N/A |
12/31/2016 | 20,453 | 2,737 | N/A | N/A | N/A |
9/30/2016 | 20,595 | 2,711 | N/A | N/A | N/A |
6/30/2016 | 20,350 | 2,276 | N/A | N/A | N/A |
3/31/2016 | 20,123 | 3,050 | N/A | 3,455 | N/A |
12/31/2015 | 19,649 | 1,680 | N/A | N/A | N/A |
9/30/2015 | 19,334 | 1,460 | N/A | N/A | N/A |
6/30/2015 | 19,018 | 861 | N/A | N/A | N/A |
3/31/2015 | 18,531 | 698 | N/A | 1,135 | N/A |
12/31/2014 | 16,632 | 1,137 | N/A | N/A | N/A |
9/30/2014 | 11,078 | 1,380 | N/A | N/A | N/A |
6/30/2014 | 11,118 | 2,194 | N/A | N/A | N/A |
3/31/2014 | 11,103 | 2,209 | N/A | 1,324 | N/A |
12/31/2013 | 11,161 | 2,230 | N/A | N/A | N/A |
9/30/2013 | 11,002 | 2,393 | N/A | N/A | N/A |
6/30/2013 | 10,736 | 2,220 | N/A | N/A | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (14.5% al año) de PFIZER es superior a la tasa de ahorro (6.7%).
Beneficios vs. Mercado: Se prevé que los beneficios (14.5% al año) de PFIZER crezcan menos que el mercado Indian (17.8% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de PFIZER crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (8.1% al año) de PFIZER crezcan más despacio que el mercado de Indian (10.3% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 8.1% al año) de PFIZER crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de PFIZER sea baja dentro de 3 años (16.4%).